Article citationsMore>>

Gilbert, S.M., et al. (2017) A Phase I Clinical Trial Demonstrates That nfP2X7 Targeted Antibodies Provide a Novel, Safe and Tolerable Topical Therapy for Basal Cell Carcinoma. The British Journal of Dermatology, 177, 117-124.
https://doi.org/10.1111/bjd.15364

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top